Principal Financial Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,434
| Closed | -$99.4K | – | 2330 |
|
|
2025
Q1 | $99.4K | Buy |
22,434
+237
| +1% | +$1.05K | ﹤0.01% | 2096 |
|
|
2024
Q4 | $174K | Buy |
22,197
+1,903
| +9% | +$14.9K | ﹤0.01% | 2117 |
|
|
2024
Q3 | $267K | Buy |
+20,294
| New | +$267K | ﹤0.01% | 2049 |
|
|
2024
Q2 | – | Sell |
-13,729
| Closed | -$223K | – | 2474 |
|
|
2024
Q1 | $223K | Sell |
13,729
-1,100
| -7% | -$17.9K | ﹤0.01% | 2149 |
|
|
2023
Q4 | $101K | Sell |
14,829
-390
| -3% | -$2.66K | ﹤0.01% | 2271 |
|
|
2023
Q3 | $82.9K | Buy |
15,219
+1,497
| +11% | +$8.16K | ﹤0.01% | 2308 |
|
|
2023
Q2 | $93.2K | Buy |
13,722
+2,770
| +25% | +$18.8K | ﹤0.01% | 2302 |
|
|
2023
Q1 | $54.9K | Sell |
10,952
-709
| -6% | -$3.55K | ﹤0.01% | 2366 |
|
|
2022
Q4 | $56.9K | Buy |
11,661
+1,270
| +12% | +$6.2K | ﹤0.01% | 2357 |
|
|
2022
Q3 | $150K | Sell |
10,391
-204
| -2% | -$2.95K | ﹤0.01% | 2258 |
|
|
2022
Q2 | $160K | Buy |
+10,595
| New | +$160K | ﹤0.01% | 2333 |
|
|
2021
Q4 | – | Sell |
-15,971
| Closed | -$455K | – | 2659 |
|
|
2021
Q3 | $455K | Buy |
15,971
+5,935
| +59% | +$169K | ﹤0.01% | 2195 |
|
|
2021
Q2 | $339K | Buy |
10,036
+1,148
| +13% | +$38.8K | ﹤0.01% | 2319 |
|
|
2021
Q1 | $269K | Sell |
8,888
-7,120
| -44% | -$215K | ﹤0.01% | 2303 |
|
|
2020
Q4 | $792K | Buy |
16,008
+7,704
| +93% | +$381K | ﹤0.01% | 1998 |
|
|
2020
Q3 | $319K | Sell |
8,304
-5,345
| -39% | -$205K | ﹤0.01% | 2118 |
|
|
2020
Q2 | $590K | Buy |
+13,649
| New | +$590K | ﹤0.01% | 1934 |
|